TiGenix Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 89

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $617M

  • Investors
  • 2

TiGenix General Information

Description

Developer of anti-inflammatory properties of stem cells is designed to offer novel therapies for serious medical conditions. The company exploits anti-inflammatory properties of stem cells to develop therapies from its proprietary technology platforms for serious medical conditions in the areas of high unmet medical need.

Contact Information

Website
www.tigenix.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Romeinse straat 12/2
  • 3001 Leuven
  • Belgium
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Laboratory Services (Healthcare)
Acquirer
Takeda Pharmaceutical
Vertical(s)
Life Sciences
Corporate Office
  • Romeinse straat 12/2
  • 3001 Leuven
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TiGenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Merger/Acquisition 04-Jan-2018 $617M Completed Generating Revenue
16. Secondary Transaction - Open Market 13-Oct-2017 Completed Generating Revenue
15. 2PO 15-Dec-2016 Completed Generating Revenue
14. PIPE 05-Jul-2016 Completed Generating Revenue
13. PIPE 10-Mar-2016 Completed Generating Revenue
12. PIPE 25-Nov-2015 Completed Generating Revenue
11. Debt - General 01-Feb-2014 Completed Generating Revenue
10. Debt - General 23-Dec-2013 Completed Generating Revenue
9. PIPE 19-Nov-2013 $25.1M $145M Completed Generating Revenue
8. PIPE 20-Dec-2012 $8.73M $120M Completed Generating Revenue
To view TiGenix’s complete valuation and funding history, request access »

TiGenix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of anti-inflammatory properties of stem cells is designed to offer novel therapies for serious medical conditi
Biotechnology
Leuven, Belgium
89 As of 2017

Madison, WI

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TiGenix Competitors (62)

One of TiGenix’s 62 competitors is Regenerative Medical Solutions, a Venture Capital-Backed company based in Madison, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenerative Medical Solutions Venture Capital-Backed Madison, WI
Neurona Therapeutics Formerly VC-backed South San Francisco, CA
Parion Sciences Venture Capital-Backed Durham, NC
Neurogene Formerly VC-backed New York, NY
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
You’re viewing 5 of 62 competitors. Get the full list »

TiGenix Patents

  • 314

    Total Documents Applications and Grants

  • Total Patents Families

  • 112

    Granted

  • 14

    Pending

  • Expiring in next 12 mo

TiGenix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022522187-A Improved stem cell population for allogeneic therapy Active 27-Feb-2019
WO-2020174002-A1 Improved stem cell populations for allogeneic therapy Inactive 27-Feb-2019
JP-2022520420-A Cryopreservation of stem cells Active 13-Feb-2019
WO-2020165152-A1 Cryopreservation of stem cells Inactive 13-Feb-2019
JP-2019508455-A Adipose tissue-derived stromal stem cells for use in the treatment of anal complex fistula in crohn's disease Active 14-Mar-2016 A61K35/35
To view TiGenix’s complete patent history, request access »

TiGenix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TiGenix Former Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
4BIO Capital Venture Capital Minority
Auriga Partners (Paris) Venture Capital Minority
BIP Capital Partners PE/Buyout Minority
BNP Paribas Fortis Private Equity Growth/Expansion Minority
BVP (Brightlands Venture Partners) Venture Capital Minority
You’re viewing 5 of 22 investors. Get the full list »

TiGenix Investments & Acquisitions (4)

TiGenix’s most recent deal was a Merger/Acquisition with Coretherapix for . The deal was made on 31-Jul-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Coretherapix 31-Jul-2015 Merger/Acquisition Drug Discovery
Cellerix 05-May-2011 Merger/Acquisition Drug Discovery
Arcarios 25-Aug-2010 Seed Round Drug Discovery
OrthoMimetics 16-Nov-2009 Merger/Acquisition Therapeutic Devices
To view TiGenix’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

TiGenix FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process